Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".
Schneller-Pavelescu L, Vergara-de Caso E, Martorell A, Romaní J, Lázaro M, Vilarrasa E, Díaz-Ley B, Vázquez-Osorio I, Segura Palacios JM, Azaña JM, González-López MA, Cañueto J, Molina-Leyva A, Leiva-Salinas M, Navarro-Triviño FJ, Sánchez-Payá J, Pascual JC.
Schneller-Pavelescu L, et al. Among authors: pascual jc.
J Am Acad Dermatol. 2023 May;88(5):e271-e272. doi: 10.1016/j.jaad.2019.03.006. Epub 2019 Mar 11.
J Am Acad Dermatol. 2023.
PMID: 30872153
No abstract available.